Results 31 to 40 of about 5,476 (161)

Cytopenia occurrence in kidney transplant recipients within early post-transplant period

Journal of Research in Pharmacy Practice, 2017
Objective: This study assessed incidence, severity, and time to occurrence of drug-induced leukopenia/thrombocytopenia within 1st month after kidney transplantation.
Atefeh Jafari, Parisa Najivash, Mohammad-Reza Khatami, Simin Dashti-Khavidaki   +3 more
doaj   +1 more source

The Polymorphism −308G/A of Tumor Necrosis Factor-α Gene Modulates the Effect of Immunosuppressive Treatment in First Kidney Transplant Subjects Who Suffer an Acute Rejection

Journal of Immunology Research, 2016
The −308G/A SNP of tumor necrosis factor-alpha (TNF-α) gene affects TNF-α production. As its impact on transplant outcome remains open to debate, we decided to genotype it in a cohort of transplant subjects.
Ana Isabel Sánchez-Fructuoso, Isabel Pérez-Flores, Rosalia Valero, Maria Angeles Moreno, Miguel Fernandez-Arquero, Elena Urcelay, Cristina Fernández-Pérez, Jose Luis Santiago   +7 more
doaj   +1 more source

Risk factors for cytomegalovirus disease in seropositive renal transplant recipients; a single-center case-controlled study [PDF]

Journal of Nephropathology, 2017
Background: Risk factors for cytomegalovirus (CMV) disease in renal transplant recipients have been evaluated in industrialized countries with relatively low CMV seroprevalence.
Viviana Navarro-Rodríguez, Alvaro Herrera-Munoz, Adrián Castro, Allan Ramos-Esquivel   +3 more
doaj   +1 more source

Population Pharmacokinetic Modeling of Thymoglobulin (R) in Children Receiving Allogeneic-Hematopoietic Cell Transplantation: Towards Improved Survival Through Individualized Dosing [PDF]

, 2015
Background and Objectives To prevent graft-versus-host disease and rejection in hematopoietic cell transplantation (HCT), children receive Thymoglobulin (R), a polyclonal antibody acting mainly by depleting T cells.
Bartelink, Imke H., Bredius, Robbert G.M., van Tol, Maarten J D, Bredius, R.G.M., van Kesteren, Charlotte, Jol-van der Zijde, Cornelia M., Knibbe, C.A.J., Bartelink, I.H., Knibbe, Catherijne A.J., Admiraal, Rick, van Tol, Maarten J.D., Bredius, Robbert G M, Boelens, Jaap Jan, Kesteren, C. van, Knibbe, Catherijne A J, Jol-van der Zijde, C.M., Tol, M.J.D. van, Boelens, J.J., Admiraal, R.   +18 more
core   +1 more source

Outcomes of abo-incompatible kidney transplantation: Novel ways of reducing rejection, complications, and cost

Transplantation Reports, 2023
Aim: Our objective was to report the outcomes of ABO-incompatible (ABOi) transplants and seek solutions to pretransplant desensitization, peri and postoperative bleeding events, acute rejection and infection-related mortality. Methods: We retrospectively
Vivek Pathak, Madhav Venkatesan, Devdas Madhavan, S Balasundaram, N Kuppurajan, Sampath kumar, Gabor Bodonyi-Kovacs   +6 more
doaj   +1 more source

The Role of Anti-Thymocyte Globulin or Alemtuzumab-Based Serotherapy in the Prophylaxis and Management of Graft-Versus-Host Disease

Biomedicines, 2017
Allogeneic hematopoietic stem cell transplant is an established treatment modality for hematologic and non-hematologic diseases. However, it is associated with acute and long-term sequelae which can translate into mortality.
Robert Ali, Jeremy Ramdial, Sandra Algaze, Amer Beitinjaneh   +3 more
doaj   +1 more source

Influence of Thymoglobulin on lymphocyte-subsets after solid organ- transplantation

, 2010
Bei der laut Deutsche Stiftung Organtransplantation (DSO) bestehenden Diskrepanz zwischen Organangebot und Nachfrage kann es heutzutage vermehrt zur Transplantation marginaler Spenderorgane kommen, was ein erhöhtes Abstoßungsrisiko mit sich bringt.
Melloh, Goetz-Christian
core   +1 more source

A randomized, double-blinded comparison of thymoglobulin versus Atgam for induction immunosuppressive therapy in adult renal transplant recipients.

, 1999
Background. The aim of this study was to compare the efficacy and safety of Thymoglobulin (a rabbit-derived polyclonal antibody) to Atgam (a horse- derived polyclonal antibody) for induction in adult renal transplant recipients. Methods.
Kano, Jennifer M, Schnitzler, Mark A, Howard, Todd K, Irish, William, Flavin, Karen, Lowell, Jeffrey A, Dolan, Sara, Woodward, Robert, Mahon, Mitchell, Singer, Gary G, Burgess, Sandra, Shenoy, Surendra, Brennan, Daniel C   +12 more
core   +1 more source

Preliminary results of a "prope" tolerogenic regimen with thymoglobulin pretreatment and hepatitis C virus recurrence in liver transplantation.

, 2005
Background. Recent reports demonstrate the efficacy of induction immunosuppression with Thymoglobulin, a potent antithymocyte polyclonal antibody, in allowing acquired tolerance by means of a tolerogenic regimen of recipient pretreatment and low-dose ...
DE RUVO N, CUCCHETTI A, RAMACCIATO, Giovanni, CUCCHETTI, ALESSANDRO, PINNA, ANTONIO DANIELE, CAUTERO N, RISALITI A, RAVAIOLI M, LAURO A, RISALITI, Andrea, DI BENEDETTO F, MOLTENI G, RAMACCIATO G, PINNA AD, DEL GAUDIO M, DI FRANCESCO F, A. RISALITI, MASETTI M, DAZZI A, DAZZI, ALESSANDRO   +19 more
core   +2 more sources

A prospective, randomized, clinical trial of intraoperative versus postoperative Thymoglobulin in adult cadaveric renal transplant recipients

, 2003
BACKGROUND: Delayed graft function (DGF) is frequently observed in recipients of cadaveric renal transplants. Previous retrospective or nonrandomized studies have suggested that intraoperative administration of polyclonal antithymocyte preparations may ...
Williams, W. W., Chandraker, A., Ko, D. S., Delmonico, F. L., Pascual, M. A., Farrell, M. L., Auchincloss, H., Goggins, W. C., Magee, C., Tolkoff-Rubin, N., Cosimi, A. B., Powelson, J. A.   +11 more
core   +1 more source